Sort
23,748 grants matching “melanoma”
TR&D2: Nanoimmunomaterials for Immune Engineering
$315,202Jordan Green · Johns Hopkins University · P41 · FY2022 · EB
Specific Recognition of G-quadruplexes
$315,186Hanbin Mao · Kent State University · R01 · FY2020 · CA
Effect of radiotherapy on dendritic cell subsets: implications for immunotherapy
$315,182Juliana Idoyaga · Stanford University · R01 · FY2021 · CA
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER
$315,180Per H. Basse · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Effect of radiotherapy on dendritic cell subsets: implications for immunotherapy
$315,107Juliana Idoyaga · Stanford University · R01 · FY2020 · CA
P53 inactivation on MDSC development and tumor progression
$315,054Yan Cui · Augusta University · R01 · FY2015 · CA
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis
$315,014Chi V. Dang · Johns Hopkins University · R01 · FY2024 · CA
Developmental Regulation of Gene Expression by Long Undecoded Transcript Isoforms
$315,010Elcin Unal · University Of California Berkeley · R01 · FY2023 · GM
Effect of radiotherapy on dendritic cell subsets: implications for immunotherapy
$314,970Juliana Idoyaga · Stanford University · R01 · FY2018 · CA
Leukocyte-Endothelial Adhesion in Tumor Immunity
$314,958Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$314,928Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2023 · CA
Regulation of extracellular vesicle biogenesis through cell adhesion
$314,925Heather H Pua · Vanderbilt University Medical Center · R01 · FY2025 · CA
Effect of radiotherapy on dendritic cell subsets: implications for immunotherapy
$314,908Juliana Idoyaga · Stanford University · R01 · FY2017 · CA
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
$314,875University Of Texas Sw Med Ctr/Dallas · R37 · FY2000 · CA
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma
$314,862Eva Hernando · New York University School Of Medicine · U54 · FY2024 · CA
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$314,841Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA
Hypoxia and Gene Repression
$314,835Amato J. Giaccia · Stanford University · R37 · FY2014 · CA
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in
$314,830David John Hunter · Brigham And Women'S Hospital · P50 · FY2009 · CA
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo
$314,768Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2014 · AR
Biology of Melanoma Matastasis
$314,767Wistar Institute · R01 · FY2005 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$314,731Jun S Song · University Of California, San Francisco · R01 · FY2012 · CA
Immune responses to gene-modified, autologous dendritic cell vaccines in melanoma
$314,717James W. Young · Sloan-Kettering Inst Can Research · R21 · FY2007 · CA
Epigenetic Regulation of Cell and Tissue Aging
$314,675Estela E Medrano · Baylor College Of Medicine · R01 · FY2007 · AG
COMBINATION ANTIANGIOGENIC THERAPY FOR ADVANCED MELANOMA
$314,610Beth Israel Deaconess Medical Center · R21 · FY2004 · CA
Targeting HSP70 in autoimmune vitiligo
$314,566Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2012 · AR